Literature DB >> 21624434

Memory of fearful events: the role of fibroblast growth factor-2 in fear acquisition and extinction.

B M Graham1, R Richardson.   

Abstract

Research during the past decade has led to a tremendous growth in our understanding of how fear memories are acquired and subsequently inhibited on a neural and molecular level. Such research has contributed to significant developments in the treatment of anxiety disorders, and has considerably advanced our understanding of the neurobiology of learning and memory in general. A number of recent studies have examined the role of growth factors in the formation of long-term memory for fearful events, due to their ability to cause morphological neural changes in response to environmental stimulation. In this review we first describe physiological evidence that fibroblast growth factor-2 (FGF2) receptors are highly expressed in the neural circuitry regulating fear acquisition and extinction, and that FGF2 modulates the molecular signals known to be involved in the formation of fear memories. Then we present emerging behavioral research that demonstrates that exogenous FGF2 can enhance the formation of fear conditioning and extinction memories. Finally, we briefly discuss how research into the role of FGF2 in learning and memory may be of clinical benefit, particularly in the treatment of anxiety disorders.
Copyright © 2011 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21624434     DOI: 10.1016/j.neuroscience.2011.05.041

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  21 in total

1.  Interaction between cholecystokinin and the fibroblast growth factor system in the ventral tegmental area of selectively bred high- and low-responder rats.

Authors:  S J Ballaz; J Perez; M Waselus; H Akil; S J Watson
Journal:  Neuroscience       Date:  2013-10-09       Impact factor: 3.590

Review 2.  Intermittent metabolic switching, neuroplasticity and brain health.

Authors:  Mark P Mattson; Keelin Moehl; Nathaniel Ghena; Maggie Schmaedick; Aiwu Cheng
Journal:  Nat Rev Neurosci       Date:  2018-01-11       Impact factor: 34.870

3.  Central Ghrelin Resistance Permits the Overconsolidation of Fear Memory.

Authors:  Elia S Harmatz; Lauren Stone; Seh Hong Lim; Graham Lee; Anna McGrath; Barbara Gisabella; Xiaoyu Peng; Eliza Kosoy; Junmei Yao; Elizabeth Liu; Nuno J Machado; Veronica S Weiner; Warren Slocum; Rodrigo A Cunha; Ki A Goosens
Journal:  Biol Psychiatry       Date:  2016-11-29       Impact factor: 13.382

Review 4.  Fear extinction as a model for translational neuroscience: ten years of progress.

Authors:  Mohammed R Milad; Gregory J Quirk
Journal:  Annu Rev Psychol       Date:  2012       Impact factor: 24.137

Review 5.  Pharmacology of cognitive enhancers for exposure-based therapy of fear, anxiety and trauma-related disorders.

Authors:  N Singewald; C Schmuckermair; N Whittle; A Holmes; K J Ressler
Journal:  Pharmacol Ther       Date:  2014-12-27       Impact factor: 12.310

6.  Individual Differences Make a Marker in Fear Research.

Authors:  Katherine E Prater
Journal:  Biol Psychiatry       Date:  2017-10-15       Impact factor: 13.382

Review 7.  The fibroblast growth factor family: neuromodulation of affective behavior.

Authors:  Cortney A Turner; Stanley J Watson; Huda Akil
Journal:  Neuron       Date:  2012-10-04       Impact factor: 17.173

Review 8.  Intergenerational Metabolic Syndrome and Neuronal Network Hyperexcitability in Autism.

Authors:  Aileen Rivell; Mark P Mattson
Journal:  Trends Neurosci       Date:  2019-09-05       Impact factor: 13.837

9.  Persistence of Fear Memory Depends on a Delayed Elevation of BAF53b and FGF1 Expression in the Lateral Amygdala.

Authors:  Miran Yoo; Seongwan Park; Inkyung Jung; Jin-Hee Han
Journal:  J Neurosci       Date:  2020-08-19       Impact factor: 6.167

10.  Selectively Bred Rats Provide a Unique Model of Vulnerability to PTSD-Like Behavior and Respond Differentially to FGF2 Augmentation Early in Life.

Authors:  Katherine E Prater; Elyse L Aurbach; Hanna K Larcinese; Taylor N Smith; Cortney A Turner; Peter Blandino; Stanley J Watson; Stephen Maren; Huda Akil
Journal:  Neuropsychopharmacology       Date:  2017-02-16       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.